Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05088317 |
Other study ID # |
2021-31 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
September 4, 2021 |
Est. completion date |
December 4, 2022 |
Study information
Verified date |
August 2023 |
Source |
Istanbul University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Volunteer female and male individuals aged 20-65 years, followed in the State Hospital
Internal Diseases Unit, diagnosed with obesity (BMI> 30 kg/m^2), and meeting the inclusion
criteria will be included in the study. The control group will consist of healthy male and
female individuals between the ages of 20-65 who have not been diagnosed with obesity. The
demographic and clinical characteristics of the participants who voluntarily accepted to
participate in the study will be questioned with the "Evaluation Form" prepared by the
researchers, and the body compositions of the participants will be evaluated. The "Charlson
Comorbidity Index (CCI)" will be used to determine the existing chronic diseases of the
participants and to evaluate participants' comorbidities. Next; the "Incremental Shuttle Walk
Test (ISWT)" will be applied to determine exercise capacity. In addition, in order to
determine the level of physical activity, a "pedometer" device will be given to the
participants, participants will be asked to carry the device on them for 7 days, and at the
end of the period, the pedometer data will be recorded. At the same time, participants will
be required to fill in the "International Physical Activity Questionnaire-Short Form
(IPAQ-SF)". Participants will be asked to fill in the "Stop-Bang Test" to assess the risk of
sleep apnea, the "Obesity-Specific Quality of Life Scale (OSQOL)" to assess the
health-related quality of life, and the "Hospital Anxiety and Depression Scale (HADS)" to
determine the anxiety and depression level of the participants. Handgrip strength will be
evaluated with a hydraulic hand dynamometer. Assessments take an average of 45 minutes is
planned.
Description:
Obesity is a serious public health problem whose prevalence is increasing day by day and is
accepted as an epidemic by the World Health Organization. Obesity; increases the risk of
developing cardiovascular and metabolic disorders such as atherosclerosis, type II diabetes
and metabolic syndrome, but also leads to some types of cancer and many musculoskeletal
disorders. In addition to all these negative diseases and syndromes, obese individuals often
experience a significant deterioration in their physical functions. At the same time, the
sedentary lifestyle, which is common in obese individuals, causes a decrease in exercise
capacity, which negatively affects the ability to perform activities of daily living. Studies
have shown that decreased exercise capacity is strongly correlated with the risk of all-cause
mortality. In addition, patients with low exercise capacity have a higher risk of regaining
the lost weight. Therefore, increasing exercise capacity is an important goal in obesity
management as well as reducing body weight. Studies show that obese individuals are generally
at risk for low physical activity levels, sleep apnea syndrome and low quality of life. On
the other hand, there is not enough information about the relationship between exercise
capacity, physical activity level, sleep apnea risk and quality of life in obese adults.
Exercise capacity; investigation of its relationship with physical activity level, sleep
apnea risk and quality of life will give an idea about the effect of exercise on these
parameters if exercise capacity is increased with a comprehensive exercise program to be
prepared for obese individuals. In conclusion, the aim of the study was to evaluate exercise
capacity in obese adults and to investigate the relationship between exercise capacity,
physical activity level, sleep apnea risk and quality of life.